Stay updated on Seagen Press Releases

Sign up to get notified when there's something new on the Seagen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Seagen Press Releases page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a new press release entry for Pfizer’s Phase 2 study in atopic dermatitis dated 03.09.2026 (March 2026). Removed a prior press release about PADCEV™ plus Keytruda™ and removed 'Search' and 'Medicines' from the page navigation.
    Difference
    3%
    Check dated 2026-03-12T20:41:02.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added the 02.27.2026 press release 'PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer' under Medicines and Research and Pipeline. Removed the older 12.16.2025 press release 'Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance' and the Pfizer logo.
    Difference
    2%
    Check dated 2026-03-05T18:11:06.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Difference
    3%
    Check dated 2026-02-26T11:48:31.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added Medicines and Research and Pipeline categories and published the 02.17.2026 press release Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer. Removed the Research and Corporate categories and deleted the 12.09.2025 press release Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma.
    Difference
    2%
    Check dated 2026-02-19T04:25:02.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added two new press releases: Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans (Corporate, 02.05.2026) and FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need (02.06.2026). Removed two December 2025 press releases: Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance (12.01.2025) and HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors (12.06.2025).
    Difference
    3%
    Check dated 2026-02-12T00:02:20.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added new press releases dated December 2025 to February 2026, including 'Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance' and 'Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss...'. Removed older items and the 'Prescription Medicines' category, reducing earlier posts such as the 11.21.2025 PADCEV+Keytruda and 11.13.2025 Metsera announcements.
    Difference
    8%
    Check dated 2026-02-05T00:26:21.000Z thumbnail image

Stay in the know with updates to Seagen Press Releases

Enter your email address, and we'll notify you when there's something new on the Seagen Press Releases page.